WOULD YOU PUT YOUR MOTHER ON RECLAST

Quote
Anonymous said:
That is the point. Zometa is roughly the same dose give more often and no afib. It was totally random for the afib and if Actonel reps are bad mouthing Reclast they better worry about the train that is about to hit them called Fosamax Generic
Click to expand...

You, my friend, are very naive if you think that "Fosamax Generic" is not going to affect your precious Reclast!!! So you tell me, how sales are going?
 






Anonymous said:
You, my friend, are very naive if you think that "Fosamax Generic" is not going to affect your precious Reclast!!! So you tell me, how sales are going?
Click to expand...

Fosomax generic is only going to help Reclast. It's going to increase the prescribing of osteroperosis meds overall by getting more physicians to start treating it. Then when patients don't tolerate it (which they won't because generics always have far worse side-effects), they either have to move on to Evista, Reclast, Boniva IV, or Forteo. Prescribing another oral bisphosphante is asinine, and if you're a physician reading this and it's something you do, then you're a f&#king r***** and you shouldn't be practicing medicine. If they can't tolerate one oral, they won't tolerate any of them.


Since Reclast is once yearly, there's no reason to prescribe Boniva IV. Forteo is far too expensive, and it's fracture data is no better than Reclast. PLUS a good majority of the patients who are on Forteo actually have a DECREASE in BMD after 2 years. It's pathetic. So whether you go off of fracture data (which you should) or BMD, Forteo has no advantage over Reclast. Plus, how many patients are going to comply with sticking a needle in themselves every single day for 2 years?
 






Anonymous said:
Fosomax generic is only going to help Reclast. It's going to increase the prescribing of osteroperosis meds overall by getting more physicians to start treating it. Then when patients don't tolerate it (which they won't because generics always have far worse side-effects), they either have to move on to Evista, Reclast, Boniva IV, or Forteo. Prescribing another oral bisphosphante is asinine, and if you're a physician reading this and it's something you do, then you're a f&#king r***** and you shouldn't be practicing medicine. If they can't tolerate one oral, they won't tolerate any of them.


Since Reclast is once yearly, there's no reason to prescribe Boniva IV. Forteo is far too expensive, and it's fracture data is no better than Reclast. PLUS a good majority of the patients who are on Forteo actually have a DECREASE in BMD after 2 years. It's pathetic. So whether you go off of fracture data (which you should) or BMD, Forteo has no advantage over Reclast. Plus, how many patients are going to comply with sticking a needle in themselves every single day for 2 years?
Click to expand...


...oh yeah, and Evista is weak. Breast cancer prevention? That's good. But when it doesn't work worth a darn in terms of fractures and has no hip data, it's far from ideal.
 






Anonymous said:
Fosomax generic is only going to help Reclast. It's going to increase the prescribing of osteroperosis meds overall by getting more physicians to start treating it. Then when patients don't tolerate it (which they won't because generics always have far worse side-effects), they either have to move on to Evista, Reclast, Boniva IV, or Forteo. Prescribing another oral bisphosphante is asinine, and if you're a physician reading this and it's something you do, then you're a f&#king r***** and you shouldn't be practicing medicine. If they can't tolerate one oral, they won't tolerate any of them.


Since Reclast is once yearly, there's no reason to prescribe Boniva IV. Forteo is far too expensive, and it's fracture data is no better than Reclast. PLUS a good majority of the patients who are on Forteo actually have a DECREASE in BMD after 2 years. It's pathetic. So whether you go off of fracture data (which you should) or BMD, Forteo has no advantage over Reclast. Plus, how many patients are going to comply with sticking a needle in themselves every single day for 2 years?
Click to expand...


When you had your brain washed did you get it waxed too? You said it ALL; doctors are going to Rx Fosamax generic as first line then IF...then IF...then IF....then IF...then IF...then Reclast!
 






Anonymous said:
When you had your brain washed did you get it waxed too? You said it ALL; doctors are going to Rx Fosamax generic as first line then IF...then IF...then IF....then IF...then IF...then Reclast!
Click to expand...

Of course they're going to prescribe generic fosamax first line.... What kind of bone-head statement is that? Even when Fosamax wasn't generic physicians would prescribe an oral first.

Nobody's saying that Reclast is going to be a 1st line therapy. But scripts for Reclast will definitely increase as more and more people fail on generic Fosamax.
 






Anonymous said:
Of course they're going to prescribe generic fosamax first line.... What kind of bone-head statement is that? Even when Fosamax wasn't generic physicians would prescribe an oral first.

Nobody's saying that Reclast is going to be a 1st line therapy. But scripts for Reclast will definitely increase as more and more people fail on generic Fosamax.
Click to expand...

and you're right, don't forget it...Reclast is 3rd line!
 






Anonymous said:
You, my friend, are very naive if you think that "Fosamax Generic" is not going to affect your precious Reclast!!! So you tell me, how sales are going?
Click to expand...

Sales are good in my area and wait for for the other indications this year. Recurrent fracture with mortality data. steroid induced and male osteo. I think you Actonel and Boniva reps better just focus on your pity data and keep praying that Fosamax generic doesn't kill you
 






Anonymous said:
Nurse Practitioner here....former rep,

I have the choice of prescribing a $4 generic alendronate which has proven and has the indication to prevent hip fractures...the kind that leads to over a 50% mortality rate or prescribe a new product which doesn't have the indication to prevent hip fractures. This one is a no brainer.

If called into court any prescriber will be asked why didn't you prescribe the only drug that has an indication to prevent hip fractures in my client? Why did my client have to pay 100 times more for a product that doesn't have the proven efficacy of a well studied generic?

Case closed....I would prescribe generic alendronate for 100% of my patients unless they can not tolerate it or currently haven osteonecrosis of the jaw, renal failure, liver failure or some other major organ problem.
Click to expand...

Wait until the other indication come this year my friend....recurrent fracture prevention with mortality data, steroid and male osteo with others to come. This is a great drug and will gain more with evey indication. Drs are beginning to embrace this wholeheartedly. MAy never be as big as Fosamax but will do better than expected.
So after your patients stop taking their Fosamax, start to think aboiut Reclast
 






To the oncology rep poster of "I know more about this product than any doctor I've called on in the last 5 years"...YOU ARE A DANGER TO SOCIETY!!! HOW can you think you know more about oncology/medicine/pharmacolgy than a physician who has spent more time in medicne than you have your entire grade school, middleschool, and high school carrer just because you've attended 5 years of APMs, DPMs, and training meetings? Check Yourself!

To the NP, Reclast is not indicated for prevention (otherwise known as osteopenia), try to keep focus on the post so that you may provide an accurate response.

To the rep that called MDs F&#king r*****s, honey...ah hell I guess they do recruit from all walks of life including cheerleaders. Just "Bring it On"
 


















To post #29. If you don't know more about your individual product than the physicians, do us all a favor.

The next time you're taking your fat butt through the drive thru, pick up a job application.

The person who posted that he/she knows more about their product than the physician didn't say they know more about medicine than a doctor. Take a moment to read.
 






I am a 59 yr old female with osteoporosis. I cannot tolerate oral bisphosphonates because of GERD. I have previously had 2 fractures (sacrum and pelvis) and have just finished 2 yrs of treatment with Forteo. I was dubious of the safety of this med at first, but had no problem with giving myself the injection once a day for 2 yrs. I did have a significant increase in bone density. My rheumatologist is now suggesting Reclast, and I have issues with it possibly causing atrial fibrillation and osteonecrosis of the jaw, but I feel I must take this medication to maintain the bone I have gained. My doc said he would have no problem subscibing this to a family member. As a consumer, I wish, though, there was more testing for saftey on all the drugs being released today. With more and more drugs being pulled off the market because of the "OOPS" factor, how can we feel good about taking something that has just hit the market. Case in point: Reclast was released in Aug of 2007 and reports of possible atrial fibrillation were released in Oct., I believe. This has still not been resolved.
I definitely do not like being on the cutting edge of medicine when it comes to pharmaceuticals. The track record of late has not been good! Dealing with the pain and repercussions of osteoporotic fractures is not fun, but wondering what the treatment might do to you is a double whammy.
 






Anonymous said:
I am a 59 yr old female with osteoporosis. I cannot tolerate oral bisphosphonates because of GERD. I have previously had 2 fractures (sacrum and pelvis) and have just finished 2 yrs of treatment with Forteo. I was dubious of the safety of this med at first, but had no problem with giving myself the injection once a day for 2 yrs. I did have a significant increase in bone density. My rheumatologist is now suggesting Reclast, and I have issues with it possibly causing atrial fibrillation and osteonecrosis of the jaw, but I feel I must take this medication to maintain the bone I have gained. My doc said he would have no problem subscibing this to a family member. As a consumer, I wish, though, there was more testing for saftey on all the drugs being released today. With more and more drugs being pulled off the market because of the "OOPS" factor, how can we feel good about taking something that has just hit the market. Case in point: Reclast was released in Aug of 2007 and reports of possible atrial fibrillation were released in Oct., I believe. This has still not been resolved.
I definitely do not like being on the cutting edge of medicine when it comes to pharmaceuticals. The track record of late has not been good! Dealing with the pain and repercussions of osteoporotic fractures is not fun, but wondering what the treatment might do to you is a double whammy.
Click to expand...

Yea right. Go back to your own board you troller. Do you really think ia 59 yr old woman would come on CAfepharma. HAHAHAHAHAHAHHAHA
Forteo sucks and can cause cancer so you better start worrying about that instead of osteonecrosis or afib ASSWIPE
 






Anonymous said:
I agree with the poster above, try orals first, use Reclast if they are not effective.
Click to expand...

I've sold Reclast since launch and to be honest...yes I would. Here's why:
1) Once a year so no sitting up to take her oral or GI issues
2) Efficacy! Only BP indicated for fracture reduction at Vert, Hip and Non-Vert
3) Tolerability (I have not had one office complain or get a callback
4) ONJ and Afib...If you read over the data and substudies, the are not concerns. Not to sound casual about 2 very serious issues, but the data is solid and remember, Zometa has been out for 10+ years and is used more frequently on worse off patients
5) It's a 1st line therapy. Again, look at the data. No matter how Novartis skews the data with their studies....It is solid data!

Yea I sell Reclast and it may look like brainwashed crap being throw out but you asked for an honest answer...There it is. Good luck!
 












To the NP:

Reclast is indicated to prevent hip fractures. Its in the PI. Has been since launch. Oh yeah..one more benefit, it's cheaper than generic fosamax. Since it is billed as a procedure and not a drug, the co-pay is an office/ or hospital co-pay depending on where you are infused. Approx-$20 at a Doctor's office, $10-$40 at a hospital. Generic fosamax at $4 a month would still be $48/ year. Reclast/ Zometa has been on the market since 2002, and is very well tested. As far as the safety concerns, an osteoporotic person is more likely to have a hip fracture than A-Fib or ONJ.
 






Anonymous said:
Nurse Practitioner here....former rep,

I have the choice of prescribing a $4 generic alendronate which has proven and has the indication to prevent hip fractures...the kind that leads to over a 50% mortality rate or prescribe a new product which doesn't have the indication to prevent hip fractures. This one is a no brainer.

If called into court any prescriber will be asked why didn't you prescribe the only drug that has an indication to prevent hip fractures in my client? Why did my client have to pay 100 times more for a product that doesn't have the proven efficacy of a well studied generic?

Case closed....I would prescribe generic alendronate for 100% of my patients unless they can not tolerate it or currently haven osteonecrosis of the jaw, renal failure, liver failure or some other major organ problem.
Click to expand...

"Spoken like a good little Merckie! While you do have info in your PI about hip data, was it repeatable? Seems FIT II didn't come out so well w/hip data and your first trial had what, 22 fracture vs 11 non/fract. patients w/one more fracture making the data insignificant?;by the way, it is not an indication--try again-both you and Actonel rep's drink so much of your kool-aid-you're beginning to believe the lies your marketing department feeds you---use your brain and think for yourself-perhaps physicians would have more respect for our industry if we gave "full-disclosure" rather than trying to mis-represent both your own data as well as that of your competitors!
 






Anonymous said:
Nurse Practitioner here....former rep,

I have the choice of prescribing a $4 generic alendronate which has proven and has the indication to prevent hip fractures...the kind that leads to over a 50% mortality rate or prescribe a new product which doesn't have the indication to prevent hip fractures. This one is a no brainer.

If called into court any prescriber will be asked why didn't you prescribe the only drug that has an indication to prevent hip fractures in my client? Why did my client have to pay 100 times more for a product that doesn't have the proven efficacy of a well studied generic?

Case closed....I would prescribe generic alendronate for 100% of my patients unless they can not tolerate it or currently haven osteonecrosis of the jaw, renal failure, liver failure or some other major organ problem.
Click to expand...

The above post is "Spoken like a good little Merckie! While you do have info in your PI about hip data, was it repeatable? Seems FIT II didn't come out so well w/hip data and your first trial had what, 22 fracture vs 11 non/fract. patients w/one more fracture making the data insignificant?;by the way, it is not an indication--try again-both you and Actonel rep's drink so much of your kool-aid-you're beginning to believe the lies your marketing department feeds you---use your brain and think for yourself-perhaps physicians would have more respect for our industry if we gave "full-disclosure" rather than trying to mis-represent both your own data as well as that of your competitors!
 






I wouldn't give Reclast to my worst enemy... this stuff is poison... get a grip people. Here is a better question...would you take Reclast??? yes, be honest. let someone drip laundry detergent into your veins that will last for a year. And if it doesn't agree with you then you are stuck for a year plus. I have spoken and read hundreds of reports from the victims of this killer drug. I only wish I had done this before late October when I took my father to get this drug. 54 days later he was DEAD... due to Reclast!!!!!!! my research has shown over 300 deaths in 2009. One death is too much!!

Go ahead , I dare you put that poison in your veins , and reap the consequences. I pray that person that was debating about taking this drug is reading this. DON'T TAKE RECLAST, unless you have a death wish.

My father said that the pain of his compressed fractures was nothing compared to the pain that he experienced with Reclast, and yes, he also developed A Fib. after he took this drug.

This is criminal, and I hope that Reclast and these other osteo poison drugs are gone soon. You people are living in a fantasy world if you believe that these drugs are really helpful. they hurt far more than they help. This is just the tip of the iceberg that is coming then these drugs are exposed!!!!!
 






Top Bottom
Back
Quote